Loading clinical trials...

RECRUITINGPhase 2NCT07271186

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

This study is researching experimental drugs called ALN-ANG3 and evinacumab (called "study drugs"). The study is focused on participants who have diabetic kidney disease. The aim of the study is to s...

Lead sponsor: Regeneron Pharmaceuticals•39 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Clinical Trials Administrator

CONTACT

844-734-6643 clinicaltrials@regeneron.com

Related studies

Active Not RecruitingPhase 1/2

Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease

NCT06866158 · Diabetic Kidney Disease (DKD)

Not Yet RecruitingPhase 1/2

Mesenchymal Stem Cells for Chronic Kidney Diseases

NCT07240987 · Kidney Disease, Chronic, Diabetic Kidney Disease (DKD), and more

Not Yet Recruiting

YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

NCT07032116 · Diabetic Kidney Disease (DKD)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 16, 2026Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment270

Start dateJan 2026

Last updatedApr 16, 2026

Condition

Diabetic Kidney Disease (DKD)

Locations shown

Applied Research Center of Arkansas

Little Rock, Arkansas

Amicis Research Center

Northridge, California

FOMAT - Vista del Mar Medical Group

Oxnard, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 16, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions